NIX-0699 | m-entrepreneurship.com

Product Name :
NIX-0699

Search keywords :
Cytochrome P450 3A4

drugId :
null

Target Vo:
Cytochrome P450 3A4

Target Vo Short Name :
CYP3A4

Moa_Name:
Cytochrome P450 3A4 inhibitors

First Approval Country :
Nigeria

First Approval Date Filter:
2006

Origin Company_Name :
National Institute For Pharmaceutical Research And Development

Active Company_Name :
National Institute For Pharmaceutical Research And Development

Active Indication_Name:
Anemia, Sickle Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Nimotuzumab Epigenetic Reader Domain
NF-KB p105 (YP7055) Mouse mAb Cancer
DLAT Antibody (YA912): DLAT Antibody (YA912) is an unconjugated, approximately 69 kDa, mouse-derived, anti-DLAT (YA912) monoclonal antibody. DLAT Antibody (YA912) can be used for: WB, ICC/IF, IP expriments in human, mouse background without labeling.

Author: Betaine hydrochloride

Related Posts